Yahoo
NasdaqGM - Nasdaq Real Time Price USD

ANI Pharmaceuticals, Inc. (ANIP)

69.69 +0.07 (+0.10%)
As of 10:23:04 AM EST. Market Open.
Trade ANIP on Coinbase
ANIP Q3 2026 earnings call
Replay the call for the latest insights.
Read transcript
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,041,343
883,366
614,376
486,816
316,385
Cost of Revenue
405,540
341,310
250,210
181,513
138,785
Gross Profit
635,803
542,056
364,166
305,303
177,600
Operating Expense
476,297
460,826
361,948
255,774
203,334
Operating Income
159,506
81,230
2,218
49,529
-25,734
Net Non Operating Interest Income Expense
-14,872
-20,060
-17,602
-26,940
-28,052
Other Income Expense
13,204
34,621
-6,828
-2,717
-8,879
Pretax Income
157,838
95,791
-22,212
19,872
-62,665
Tax Provision
40,996
17,454
-3,690
1,093
-14,769
Net Income Common Stockholders
109,879
70,217
-20,147
15,475
-49,521
Average Dilution Earnings
--
352
0
16
--
Diluted NI Available to Com Stockholders
110,231
70,569
-20,147
15,491
-49,521
Basic EPS
4.83
3.50
-1.04
0.86
-3.05
Diluted EPS
4.59
3.32
-1.04
0.85
-3.05
Basic Average Shares
20,710.50
20,053
19,318
18,001
16,260
Diluted Average Shares
22,032
21,228
19,318
18,194
16,260
Total Operating Income as Reported
166,488
111,093
584
46,971
-35,283
Total Expenses
881,837
802,136
612,158
437,287
342,119
Net Income from Continuing & Discontinued Operation
116,842
78,337
-18,522
18,779
-47,896
Normalized Income
106,690
51,599.03
-16,190.97
21,196.31
-40,600.56
Interest Expense
14,872
20,060
17,602
26,940
28,052
Net Interest Income
-14,872
-20,060
-17,602
-26,940
-28,052
EBIT
172,710
115,851
-4,610
46,812
-34,613
EBITDA
255,434
207,268
63,121
106,603
25,040
Reconciled Cost of Revenue
405,540
341,310
250,210
181,513
136,104
Reconciled Depreciation
82,724
91,417
67,731
59,791
59,653
Net Income from Continuing Operation Net Minority Interest
116,842
78,337
-18,522
18,779
-47,896
Total Unusual Items Excluding Goodwill
13,714
32,687
-2,795
-2,558
-9,549
Total Unusual Items
13,714
32,687
-2,795
-2,558
-9,549
Normalized EBITDA
241,720
174,581
65,916
109,161
34,589
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
3,562
5,949.03
-463.97
-140.69
-2,253.56
12/31/2022 - 5/5/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: